Jan Olofsson

Division Chief – Reproductive Medicine

Sidra Medical and Research Center



Prof. Olofsson graduated with his MD degree from Umeå University, Sweden (1986), and obtained his PhD in Reproductive Endocrinology, Umeå University, Sweden (1991). During 1992 – 1994 he was Research Fellow in Reproductive Medicine at the University of British Columbia, Vancouver, Canada, where he primarily undertook the molecular characterization of the gene encoding the human GnRH receptor. He was appointed Associate Professor of Physiology (1995) and subsequently, in Obstetrics and Gynecology (1999). He is since 2017 appointed as Division Chief of Reproductive Medicine at Sidra Medical and Research Center in Doha, Qatar to oversee the completion of a novel state-of-the art large unit, slated to open in 2018. This will be a ultramodern, all-digital, academic and full service center, which will set new standards in patient care for infertile couples in Qatar, the Gulf region and internationally. In his previous role, he was the Clinical Director and Head of Reproductive Medicine at Karolinska University Hospital, Stockholm, Sweden. This unit provides a complete range of fertility services for the greater Stockholm area (pop. 2.3 million), including assisting reproductive treatments (ART) such as IVF, ICSI, frozen embryo cycles, donor gametes, PGD and fertility preservation, with over 2800 treatment cycles started per year. Prior, he was the Asia Pacific Regional Director Medical Affairs for Reproductive Medicine at Organon, Schering-Plough and most recently MSD (Merck Inc), between 2006 - 2012. In this role, he directed the strategy for regional and global medical-marketing plans, new product launch including planning, market research, positioning and messaging, and ongoing assessment of performance. He provided scientific input Phase III-V clinical studies and educational grant projects in the Asia-Pacific region. He chaired several ad hoc medical advisory committees in Women's Reproductive Health and Fertility, and has organized and moderated scientific meetings across Asia, Europe, North and South America. A/Prof. Olofsson’s research interests in reproductive medicine lie primarily in ovarian function and ART program management and quality control. To date, he has contributed more than 60 scholarly articles to the scientific and medical communities, and he has successfully supervised six PhD students. A/Prof. Olofsson is a member of several prestigious professional societies and he has delivered numerous invited lectures globally.